Logo image of MORF

MORPHIC HOLDING INC (MORF) Stock Fundamental Analysis

USA - NASDAQ:MORF - US61775R1059 - Common Stock

56.99 USD
+0.02 (+0.04%)
Last: 8/15/2024, 8:13:37 PM
56.99 USD
0 (0%)
After Hours: 8/15/2024, 8:13:37 PM
Fundamental Rating

3

MORF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. While MORF has a great health rating, there are worries on its profitability. MORF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MORF has reported negative net income.
MORF had a negative operating cash flow in the past year.
In the past 5 years MORF always reported negative net income.
MORF had a negative operating cash flow in each of the past 5 years.
MORF Yearly Net Income VS EBIT VS OCF VS FCFMORF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

1.2 Ratios

With a decent Return On Assets value of -27.83%, MORF is doing good in the industry, outperforming 71.70% of the companies in the same industry.
MORF has a Return On Equity of -29.08%. This is amongst the best in the industry. MORF outperforms 81.02% of its industry peers.
Industry RankSector Rank
ROA -27.83%
ROE -29.08%
ROIC N/A
ROA(3y)-19.83%
ROA(5y)-19.11%
ROE(3y)-22.37%
ROE(5y)-25.77%
ROIC(3y)N/A
ROIC(5y)N/A
MORF Yearly ROA, ROE, ROICMORF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

MORF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MORF Yearly Profit, Operating, Gross MarginsMORF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 -10K -20K -30K

More info and screens

8

2. Health

2.1 Basic Checks

MORF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MORF has been increased compared to 1 year ago.
Compared to 5 years ago, MORF has more shares outstanding
MORF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MORF Yearly Shares OutstandingMORF Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MORF Yearly Total Debt VS Total AssetsMORF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 60.78 indicates that MORF is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 60.78, MORF belongs to the best of the industry, outperforming 98.42% of the companies in the same industry.
There is no outstanding debt for MORF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 60.78
ROIC/WACCN/A
WACC10.56%
MORF Yearly LT Debt VS Equity VS FCFMORF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

MORF has a Current Ratio of 24.13. This indicates that MORF is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MORF (24.13) is better than 95.43% of its industry peers.
MORF has a Quick Ratio of 24.13. This indicates that MORF is financially healthy and has no problem in meeting its short term obligations.
MORF has a better Quick ratio (24.13) than 95.43% of its industry peers.
Industry RankSector Rank
Current Ratio 24.13
Quick Ratio 24.13
MORF Yearly Current Assets VS Current LiabilitesMORF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MORF have decreased strongly by -15.74% in the last year.
MORF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
The Revenue for MORF have been decreasing by -31.12% on average. This is quite bad
EPS 1Y (TTM)-15.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-77.37%
Revenue growth 5Y-31.12%
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 0.11% on average over the next years.
MORF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 213.82% yearly.
EPS Next Y-16.05%
EPS Next 2Y-11.1%
EPS Next 3Y-8.78%
EPS Next 5Y0.11%
Revenue Next Year-50.42%
Revenue Next 2Y-24.72%
Revenue Next 3Y-7.43%
Revenue Next 5Y213.82%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MORF Yearly Revenue VS EstimatesMORF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
MORF Yearly EPS VS EstimatesMORF Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MORF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MORF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MORF Price Earnings VS Forward Price EarningsMORF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MORF Per share dataMORF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

MORF's earnings are expected to decrease with -8.78% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.1%
EPS Next 3Y-8.78%

More info and screens

0

5. Dividend

5.1 Amount

MORF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MORPHIC HOLDING INC

NASDAQ:MORF (8/15/2024, 8:13:37 PM)

After market: 56.99 0 (0%)

56.99

+0.02 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)07-25 2024-07-25/bmo
Earnings (Next)11-01 2024-11-01/bmo
Inst Owners1.36%
Inst Owner Change0%
Ins Owners15.53%
Ins Owner Change0%
Market Cap2.85B
Revenue(TTM)N/A
Net Income(TTM)-179824000
Analysts73.33
Price Target59.6 (4.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.15%
Min EPS beat(2)-15.97%
Max EPS beat(2)3.68%
EPS beat(4)2
Avg EPS beat(4)0.47%
Min EPS beat(4)-15.97%
Max EPS beat(4)25.02%
EPS beat(8)4
Avg EPS beat(8)3.24%
EPS beat(12)6
Avg EPS beat(12)16.34%
EPS beat(16)7
Avg EPS beat(16)16.75%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.22%
PT rev (3m)0.22%
EPS NQ rev (1m)1.34%
EPS NQ rev (3m)-2.79%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-12.5%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.62
P/tB 4.62
EV/EBITDA N/A
EPS(TTM)-3.75
EYN/A
EPS(NY)-4.33
Fwd EYN/A
FCF(TTM)-2.75
FCFYN/A
OCF(TTM)-2.72
OCFYN/A
SpS0
BVpS12.35
TBVpS12.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.83%
ROE -29.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.83%
ROA(5y)-19.11%
ROE(3y)-22.37%
ROE(5y)-25.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.75%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.13
Quick Ratio 24.13
Altman-Z 60.78
F-Score2
WACC10.56%
ROIC/WACCN/A
Cap/Depr(3y)83.14%
Cap/Depr(5y)112.12%
Cap/Sales(3y)81.29%
Cap/Sales(5y)51.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y-16.05%
EPS Next 2Y-11.1%
EPS Next 3Y-8.78%
EPS Next 5Y0.11%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-77.37%
Revenue growth 5Y-31.12%
Sales Q2Q%N/A
Revenue Next Year-50.42%
Revenue Next 2Y-24.72%
Revenue Next 3Y-7.43%
Revenue Next 5Y213.82%
EBIT growth 1Y-49.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-29.66%
EBIT Next 3Y-21.14%
EBIT Next 5YN/A
FCF growth 1Y-41.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.79%
OCF growth 3YN/A
OCF growth 5YN/A

MORPHIC HOLDING INC / MORF FAQ

Can you provide the ChartMill fundamental rating for MORPHIC HOLDING INC?

ChartMill assigns a fundamental rating of 3 / 10 to MORF.


Can you provide the valuation status for MORPHIC HOLDING INC?

ChartMill assigns a valuation rating of 0 / 10 to MORPHIC HOLDING INC (MORF). This can be considered as Overvalued.


How profitable is MORPHIC HOLDING INC (MORF) stock?

MORPHIC HOLDING INC (MORF) has a profitability rating of 1 / 10.


Can you provide the financial health for MORF stock?

The financial health rating of MORPHIC HOLDING INC (MORF) is 8 / 10.